Table of Content

1 INTRODUCTION 32
1.1 STUDY OBJECTIVES 32
1.2 MARKET DEFINITION 33
1.2.1 INCLUSIONS AND EXCLUSIONS 33
1.3 STUDY SCOPE 34
1.3.1 YEARS CONSIDERED 35
1.4 CURRENCY CONSIDERED 35
1.5 STAKEHOLDERS 36
2 RESEARCH METHODOLOGY 37
2.1 RESEARCH APPROACH 37
2.1.1 SECONDARY DATA 38
2.1.1.1 Key data from secondary sources 40
2.1.2 PRIMARY DATA 40
2.1.2.1 Key data from primary sources 42
2.1.2.2 Key industry insights 43
2.2 MARKET SIZE ESTIMATION 45
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 51
2.4 MARKET SHARE ESTIMATION 51
2.5 RESEARCH ASSUMPTIONS 52
2.6 RISK ASSESSMENT 52
2.7 RESEARCH LIMITATIONS 53
2.7.1 METHODOLOGY-RELATED LIMITATIONS 53
2.7.2 SCOPE-RELATED LIMITATIONS 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 60
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN VETERINARY DERMATOLOGY MARKET 60
4.2 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET OVERVIEW 61
4.3 VETERINARY DERMATOLOGY MARKET: REGIONAL MIX 62
4.4 VETERINARY DERMATOLOGY MARKET, BY COUNTRY 62
4.5 VETERINARY DERMATOLOGY MARKET: EMERGING VS. DEVELOPED MARKETS 63
?
5 MARKET OVERVIEW 64
5.1 INTRODUCTION 64
5.2 MARKET DYNAMICS 65
5.2.1 DRIVERS 65
5.2.1.1 Expanding companion animal population and pet ownership 65
5.2.1.2 Growing concerns about infectious zoonotic diseases 68
5.2.1.3 Rising awareness initiatives by government and animal welfare organizations 70
5.2.1.4 Increasing adoption of pet insurance and high animal healthcare expenditure 70
5.2.2 RESTRAINTS 72
5.2.2.1 Rising pet care costs 72
5.2.2.2 Restrictions on use of parasiticides for food-producing animals 72
5.2.3 OPPORTUNITIES 73
5.2.3.1 Technological advancements and product launches 73
5.2.3.2 High growth potential in emerging economies 73
5.2.3.3 Surging number of veterinary practitioners in developed markets 74
5.2.4 CHALLENGES 75
5.2.4.1 Growing resistance to parasiticides 75
5.2.4.2 Diversity in parasite species 76
5.3 INDUSTRY TRENDS 76
5.3.1 RISE IN PET OWNERSHIP, HUMANIZATION OF PETS, AND INCREASED FOCUS ON PET WELLNESS PROGRAMS 76
5.3.2 RISING USE OF DIAGNOSTICS AND WEARABLE TECHNOLOGY FOR EARLY DETECTION 76
5.4 TECHNOLOGY ANALYSIS 77
5.4.1 KEY TECHNOLOGIES 77
5.4.1.1 Topical nanomedicine 77
5.4.1.2 Biologic therapies 77
5.4.2 COMPLEMENTARY TECHNOLOGIES 78
5.4.2.1 Phototherapy 78
5.4.2.2 Hydrotherapy 78
5.4.3 ADJACENT TECHNOLOGIES 78
5.4.3.1 Telemedicine platforms 79
5.4.3.2 Wearable devices 79
5.5 PORTER’S FIVE FORCES ANALYSIS 79
5.5.1 COMPETITIVE RIVALRY 80
5.5.1.1 Established players 80
5.5.1.2 Continuous innovation 80
5.5.2 BARGAINING POWER OF BUYERS 80
5.5.2.1 Consolidated veterinary groups 80
5.5.2.2 Demand for affordable solutions 80
?
5.5.3 BARGAINING POWER OF SUPPLIERS 80
5.5.3.1 Specialized raw materials 80
5.5.3.2 Quality compliance 80
5.5.4 THREAT OF SUBSTITUTES 81
5.5.4.1 Limited alternatives 81
5.5.4.2 Specialized treatments 81
5.5.5 THREAT OF NEW ENTRANTS 81
5.5.5.1 High R&D costs 81
5.5.5.2 Regulatory requirements 81
5.6 REGULATORY LANDSCAPE 82
5.6.1 REGULATORY ANALYSIS 82
5.6.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
5.7 PATENT ANALYSIS 87
5.7.1 PATENT PUBLICATION TRENDS FOR VETERINARY DERMATOLOGY MARKET 87
5.7.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 88
5.8 TRADE ANALYSIS 91
5.8.1 IMPORT AND EXPORT SCENARIO FOR VETERINARY DERMATOLOGY PRODUCTS 91
5.9 PRICING ANALYSIS 92
5.9.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT TYPE 92
5.9.2 AVERAGE SELLING PRICE TREND OF VETERINARY DERMATOLOGY PRODUCT TYPES, BY REGION 93
5.10 REIMBURSEMENT ANALYSIS 95
5.11 KEY CONFERENCES AND EVENTS 96
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 97
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS 97
5.12.2 BUYING CRITERIA 97
5.13 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98
5.14 IMPACT OF GENERATIVE AI ON VETERINARY DERMATOLOGY MARKET 99
5.15 ECOSYSTEM ANALYSIS 99
5.16 CASE STUDY ANALYSIS 101
5.16.1 ZOETIS LAUNCHED APOQUEL TABLET FOR ALLERGIC DERMATITIS 101
5.16.2 ELANCO LAUNCHED ZENRELIA TABLET FOR CANINE ATOPIC DERMATITIS 102
5.16.3 VIRBAC LAUNCHED ALLERDERM SPOT-ON TOPICAL PRODUCT FOR SKIN BARRIER REPAIR 102
5.17 SUPPLY CHAIN ANALYSIS 103
5.18 VALUE CHAIN ANALYSIS 104
5.19 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET 105
5.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 106
5.21 INVESTMENT AND FUNDING SCENARIO 107
?
6 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 108
6.1 INTRODUCTION 109
6.2 TOPICAL 109
6.2.1 HIGH PREVALENCE OF ECTOPARASITIC INFESTATIONS AMONG PETS TO DRIVE DEMAND 109
6.3 INJECTABLES 113
6.3.1 RAPID ABSORPTION AND HIGH BIOAVAILABILITY TO FUEL GROWTH OF INJECTABLE PRODUCTS 113
6.4 ORAL 115
6.4.1 COMPREHENSIVE APPROACH TO MANAGING CHRONIC AND SEVERE DERMATOLOGICAL DISORDERS 115
7 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 117
7.1 INTRODUCTION 118
7.2 ANTIPARASITIC DRUGS 118
7.2.1 HIGH PREVALENCE OF PARASITIC INFECTIONS IN ANIMALS TO DRIVE DEMAND 118
7.3 ANTIFUNGAL DRUGS 122
7.3.1 INCREASING INSTANCES OF YEAST DERMATITIS AND CANDIDIASIS TO DRIVE DEMAND 122
7.4 ANTIBACTERIAL DRUGS 125
7.4.1 GROWTH HINDERED BY RISING CONCERNS OVER ANTIMICROBIAL RESISTANCE 125
7.5 MONOCLONAL ANTIBODIES 127
7.5.1 RISING INVESTMENT IN R&D TO BOOST SEGMENTAL GROWTH 127
7.6 OTHER PRODUCT TYPES 129
8 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 131
8.1 INTRODUCTION 132
8.2 PARASITIC INFECTIONS 132
8.2.1 HIGH OCCURRENCE IN BOTH COMPANION AND LIVESTOCK ANIMALS TO DRIVE DEMAND FOR PREVENTIVE MEASURES 132
8.3 INFECTIOUS DISEASES 134
8.3.1 HIGH PREVALENCE OF FUNGAL INFECTIONS TO DRIVE GROWTH 134
8.4 AUTOIMMUNE SKIN DISEASES 136
8.4.1 LOWER OCCURRENCE OF THESE DISEASES CONTRIBUTE TO SMALLER MARKET SHARE 136
8.5 SKIN CANCER 138
8.5.1 GROWING AWARENESS ABOUT IMPORTANCE OF EARLY DETECTION AND TREATMENT OF SKIN CANCER TO DRIVE GROWTH 138
8.6 OTHER CONDITION TYPES 140
?
9 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 142
9.1 INTRODUCTION 143
9.2 COMPANION ANIMALS 143
9.2.1 DOGS 146
9.2.1.1 Growing dog population and high pet ownership to drive growth 146
9.2.2 CATS 148
9.2.2.1 Growing awareness of feline health to drive growth 148
9.2.3 HORSES 150
9.2.3.1 Initiatives related to adoption to drive growth 150
9.2.4 OTHER COMPANION ANIMALS 152
9.3 LIVESTOCK ANIMALS 154
9.3.1 CATTLE 156
9.3.1.1 Economic importance of dairy and beef cattle to drive growth 156
9.3.2 SWINE 158
9.3.2.1 Rising global swine population and pork consumption to drive growth 158
9.3.3 POULTRY 160
9.3.3.1 Increasing demand for milk and dairy products to drive growth 160
9.3.4 OTHER LIVESTOCK ANIMALS 162
10 VETERINARY DERMATOLOGY MARKET, BY END USER 164
10.1 INTRODUCTION 165
10.2 VETERINARY HOSPITALS AND CLINICS 165
10.2.1 GROWING DEMAND FOR SPECIALIZED SKINCARE AND TREATMENTS TO DRIVE MARKET 165
10.3 ANIMAL SHELTERS AND RESCUES 167
10.3.1 NGO AND ANIMAL WELFARE ORGANIZATIONS TO KEEP SUPPORTING DERMATOLOGICAL TREATMENT IN VETERINARY MARKET 167
10.4 OTHER END USERS 169
11 VETERINARY DERMATOLOGY MARKET, BY REGION 171
11.1 INTRODUCTION 172
11.2 NORTH AMERICA 173
11.2.1 MACROECONOMIC OUTLOOK 173
11.2.2 US 179
11.2.2.1 High pet ownership rates to drive growth 179
11.2.3 CANADA 183
11.2.3.1 Rising concerns about pet skin health to drive market 183
11.3 EUROPE 187
11.3.1 MACROECONOMIC OUTLOOK 187
11.3.2 GERMANY 192
11.3.2.1 Rising poultry consumption and dairy industry to drive market 192
?
11.3.3 UK 196
11.3.3.1 Large pet ownership and zoonotic disease prevention to drive market 196
11.3.4 FRANCE 200
11.3.4.1 Stable animal healthcare spending to support market growth 200
11.3.5 ITALY 203
11.3.5.1 Expanding livestock industry to drive market 203
11.3.6 SWITZERLAND 206
11.3.6.1 High standards in animal health to drive growth 206
11.3.7 SPAIN 210
11.3.7.1 Growing pet population and strong dairy industry to drive market 210
11.3.8 REST OF EUROPE 213
11.4 ASIA PACIFIC 217
11.4.1 MACROECONOMIC OUTLOOK 217
11.4.2 JAPAN 223
11.4.2.1 Rising demand for animal products and increasing pet ownership to drive growth 223
11.4.3 CHINA 227
11.4.3.1 Expanding urban pet market and high meat consumption to fuel market 227
11.4.4 INDIA 231
11.4.4.1 Growing pet adoption and veterinary shortage to drive market 231
11.4.5 AUSTRALIA 235
11.4.5.1 Growing pet ownership and rising spending on veterinary care to drive market 235
11.4.6 NEW ZEALAND 238
11.4.6.1 Increased pet ownership and demand for advanced dermatology treatments to drive market 238
11.4.7 SOUTH KOREA 242
11.4.7.1 Increasing awareness and adoption of preventive healthcare measures to drive market 242
11.4.8 REST OF ASIA PACIFIC 245
11.5 LATIN AMERICA 249
11.5.1 MACROECONOMIC OUTLOOK 249
11.5.2 BRAZIL 254
11.5.2.1 Strong veterinary infrastructure and expanding livestock industry to drive market 254
11.5.3 MEXICO 258
11.5.3.1 Expanding livestock and poultry sectors to drive market 258
11.5.4 REST OF LATIN AMERICA 261
11.6 MIDDLE EAST & AFRICA 264
11.6.1 MACROECONOMIC OUTLOOK 264
11.6.2 GCC COUNTRIES 268
11.6.2.1 Kingdom of Saudi Arabia (KSA) 271
11.6.2.1.1 Vision 2030 investments to drive market 271
11.6.2.2 United Arab Emirates (UAE) 274
11.6.2.2.1 Significant livestock population to fuel demand 274
11.6.2.3 Rest of GCC Countries 277
11.6.3 REST OF MIDDLE EAST & AFRICA 280
12 COMPETITIVE LANDSCAPE 284
12.1 OVERVIEW 284
12.2 KEY PLAYER STRATEGY/RIGHT TO WIN 284
12.3 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020–2024) 285
12.4 MARKET SHARE ANALYSIS, 2024 286
12.4.1 RANKING OF KEY MARKET PLAYERS, 2024 289
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 289
12.5.1 STARS 289
12.5.2 EMERGING LEADERS 289
12.5.3 PERVASIVE PLAYERS 289
12.5.4 PARTICIPANTS 290
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 291
12.5.5.1 Company footprint 291
12.5.5.2 Region footprint 292
12.5.5.3 Route of administration footprint 293
12.5.5.4 Product type footprint 294
12.5.5.5 Condition type footprint 295
12.5.5.6 Animal type footprint 296
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 297
12.6.1 PROGRESSIVE COMPANIES 297
12.6.2 RESPONSIVE COMPANIES 297
12.6.3 DYNAMIC COMPANIES 297
12.6.4 STARTING BLOCKS 297
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 299
12.7 BRAND/PRODUCT COMPARISON 301
12.8 R&D EXPENDITURE OF KEY PLAYERS 302
12.9 COMPANY VALUATION AND FINANCIAL METRICS 302
12.9.1 COMPANY VALUATION 302
12.9.2 FINANCIAL METRICS 303
12.10 COMPETITIVE SCENARIO 303
12.10.1 PRODUCT APPROVALS/LAUNCHES 303
12.10.2 DEALS 304
12.10.3 EXPANSIONS 305
12.10.4 OTHER DEVELOPMENTS 306
?
13 COMPANY PROFILES 307
13.1 KEY PLAYERS 307
13.1.1 ELANCO ANIMAL HEALTH INCORPORATED 307
13.1.1.1 Business overview 307
13.1.1.2 Products offered 308
13.1.1.3 Recent developments 310
13.1.1.3.1 Product launches and approvals 310
13.1.1.3.2 Deals 310
13.1.1.3.3 Expansions 311
13.1.1.4 MnM view 311
13.1.1.4.1 Right to win 311
13.1.1.4.2 Strategic choices 311
13.1.1.4.3 Weaknesses and competitive threats 312
13.1.2 MERCK & CO., INC 313
13.1.2.1 Business overview 313
13.1.2.2 Products offered 314
13.1.2.3 Recent developments 315
13.1.2.3.1 Product launches and approvals 315
13.1.2.3.2 Deals 316
13.1.2.3.3 Expansions 317
13.1.2.3.4 Other developments 317
13.1.2.4 MnM view 317
13.1.2.4.1 Right to win 317
13.1.2.4.2 Strategic choices 318
13.1.2.4.3 Weaknesses and competitive threats 318
13.1.3 VIRBAC 319
13.1.3.1 Business overview 319
13.1.3.2 Products offered 320
13.1.3.3 Recent developments 321
13.1.3.3.1 Deals 321
13.1.3.3.2 Expansions 322
13.1.3.3.3 Other developments 322
13.1.3.4 MnM view 322
13.1.3.4.1 Right to win 322
13.1.3.4.2 Strategic choices 323
13.1.3.4.3 Weaknesses and competitive threats 323
?
13.1.4 ZOETIS INC. 324
13.1.4.1 Business overview 324
13.1.4.2 Products offered 325
13.1.4.3 Recent developments 326
13.1.4.3.1 Product launches and approvals 326
13.1.4.3.2 Deals 327
13.1.4.3.3 Expansions 327
13.1.4.3.4 Other developments 328
13.1.4.4 MnM view 328
13.1.4.4.1 Right to win 328
13.1.4.4.2 Strategic choices 328
13.1.4.4.3 Weaknesses and competitive threats 329
13.1.5 BOEHRINGER INGELHEIM INTERNATIONAL GMBH 330
13.1.5.1 Business overview 330
13.1.5.2 Products offered 331
13.1.5.3 Recent developments 332
13.1.5.3.1 Product approvals 332
13.1.5.3.2 Deals 332
13.1.5.4 MnM view 332
13.1.5.4.1 Right to win 332
13.1.5.4.2 Strategic choices 333
13.1.5.4.3 Weaknesses and competitive threats 333
13.1.6 VETOQUINOL 334
13.1.6.1 Business overview 334
13.1.6.2 Products offered 335
13.1.6.3 Recent developments 336
13.1.6.3.1 Product approvals 336
13.1.7 DECHRA PHARMACEUTICALS PLC 337
13.1.7.1 Business overview 337
13.1.7.2 Products offered 338
13.1.7.3 Recent developments 339
13.1.7.3.1 Product approvals 339
13.1.7.3.2 Deals 340
13.1.8 HESTER BIOSCIENCES LIMITED 341
13.1.8.1 Business overview 341
13.1.8.2 Products offered 343
13.1.9 PETIQ, INC. 344
13.1.9.1 Business overview 344
13.1.9.2 Products offered 345
13.1.9.3 Recent developments 346
13.1.9.3.1 Other developments 346
?
13.1.10 OUROFINO SAUDE ANIMAL 347
13.1.10.1 Business overview 347
13.1.10.2 Products offered 348
13.1.11 SWEDENCARE 349
13.1.11.1 Business overview 349
13.1.11.2 Products offered 350
13.1.11.3 Recent developments 351
13.1.11.3.1 Deals 351
13.1.12 ORION CORPORATION 353
13.1.12.1 Business overview 353
13.1.12.2 Products offered 354
13.1.13 NORBROOK 355
13.1.13.1 Business overview 355
13.1.13.2 Products offered 356
13.1.13.3 Recent developments 357
13.1.13.3.1 Product launches 357
13.1.13.3.2 Expansions 358
13.1.14 CEVA SANTE ANIMALE 359
13.1.14.1 Business overview 359
13.1.14.2 Products offered 359
13.1.14.3 Recent developments 360
13.1.14.3.1 Deals 360
13.1.15 BIMEDA, INC. 361
13.1.15.1 Business overview 361
13.1.15.2 Products offered 361
13.1.15.3 Recent developments 362
13.1.15.3.1 Product launches 362
13.1.15.3.2 Deals 362
13.2 OTHER PLAYERS 363
13.2.1 INDIAN IMMUNOLOGICALS LTD. 363
13.2.2 VETANCO 364
13.2.3 CHANELLE PHARMA 365
13.2.4 PEGASUS LABORATORIES, INC. 366
13.2.5 KYORITSU SEIYAKU CORPORATION 367
13.2.6 AVET HEALTH 368
13.2.7 ANIMALDERMA SRLS 369
13.2.8 LETI PHARMA 370
13.2.9 HUVEPHARMA, INC. 371
13.2.10 VETPLUS 372
?
14 APPENDIX 373
14.1 DISCUSSION GUIDE 373
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 381
14.3 CUSTOMIZATION OPTIONS 383
14.4 RELATED REPORTS 383
14.5 AUTHOR DETAILS 384



List of Figures

FIGURE 1 VETERINARY DERMATOLOGY MARKET SCOPE AND REGIONS COVERED 34
FIGURE 2 RESEARCH DESIGN 37
FIGURE 3 PRIMARY SOURCES 41
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 43
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 44
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 44
FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION 45
FIGURE 8 REVENUE ESTIMATION APPROACH: ZOETIS INC. 46
FIGURE 9 VETERINARY DERMATOLOGY MARKET (2024): SUPPLY-SIDE ANALYSIS 47
FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2030) 48
FIGURE 11 CAGR PROJECTIONS: SUPPLY SIDE ANALYSIS 49
FIGURE 12 TOP-DOWN APPROACH 49
FIGURE 13 DATA TRIANGULATION METHODOLOGY 51
FIGURE 14 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 2025 VS. 2030 (USD MILLION) 54
FIGURE 15 VETERINARY DERMATOLOGY MARKET, BY PRODUCT 2025 VS. 2030 (USD MILLION) 55
FIGURE 16 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2025 VS. 2030 (USD MILLION) 55
FIGURE 17 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2025 VS. 2030 (USD MILLION) 56
FIGURE 18 VETERINARY DERMATOLOGY MARKET FOR COMPANION ANIMALS 2025 VS. 2030 (USD MILLION) 57
FIGURE 19 VETERINARY DERMATOLOGY MARKET FOR LIVESTOCK ANIMALS 2025 VS. 2030 (USD MILLION) 57
FIGURE 20 VETERINARY DERMATOLOGY MARKET, BY END USER 2025 VS. 2030 (USD MILLION) 58
FIGURE 21 GEOGRAPHIC SNAPSHOT: ASIA PACIFIC TO WITNESS HIGHEST
GROWTH RATE DURING FORECAST PERIOD 59
FIGURE 22 RISING PET POPULATION AND OWNERSHIP TO DRIVE VETERINARY
DERMATOLOGY MARKET 60
FIGURE 23 ANTIPARASITIC DRUGS ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, IN 2024 61
FIGURE 24 NORTH AMERICA TO DOMINATE MARKET DURING FORECAST PERIOD 62
FIGURE 25 NEW ZEALAND TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 62
FIGURE 26 DEVELOPED MARKETS TO REGISTER HIGHER GROWTH THAN EMERGING MARKETS DURING FORECAST PERIOD 63
FIGURE 27 VETERINARY DERMATOLOGY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
FIGURE 28 PET POPULATION IN MAJOR MARKETS IN 2022 (MILLION) 66
FIGURE 29 EUROPE: PET POPULATION, 2021–2023 68
FIGURE 30 TOTAL INSURED PETS IN US, 2019–2023 71
FIGURE 31 TOTAL INSURED PETS IN CANADA, 2019–2023 71
FIGURE 32 TOTAL NUMBER OF VETERINARIANS IN US, BY GENDER, 2020–2023 74
FIGURE 33 NUMBER OF VETERINARIANS IN TOP 5 EUROPEAN COUNTRIES, 2023 75
FIGURE 34 VETERINARY DERMATOLOGY MARKET: PORTER’S FIVE FORCES ANALYSIS 82
FIGURE 35 DEVELOPMENT & APPROVAL PROCESS FOR ANIMAL PHARMACEUTICAL PRODUCTS 84
FIGURE 36 PATENT PUBLICATION TRENDS, JANUARY 2014–DECEMBER 2024 88
FIGURE 37 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTIONS) FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024) 89
FIGURE 38 TOP APPLICANT COUNTRIES/REGIONS FOR VETERINARY DERMATOLOGY PATENTS (JANUARY 2014–DECEMBER 2024) 89
FIGURE 39 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE 2022–2024 92
FIGURE 40 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES BY REGION, 2024 94
FIGURE 41 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 97
FIGURE 42 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS 97
FIGURE 43 VETERINARY DERMATOLOGY MARKET: ECOSYSTEM ANALYSIS 100
FIGURE 44 VETERINARY DERMATOLOGY MARKET: SUPPLY CHAIN ANALYSIS 104
FIGURE 45 VETERINARY DERMATOLOGY MARKET: VALUE CHAIN ANALYSIS 105
FIGURE 46 ADJACENT MARKETS FOR VETERINARY DERMATOLOGY MARKET 105
FIGURE 47 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS IN
VETERINARY DERMATOLOGY MARKET 106
FIGURE 48 INVESTMENT AND FUNDING ACTIVITIES IN VETERINARY
DERMATOLOGY MARKET, 2020–2024 107
FIGURE 49 VETERINARY DERMATOLOGY MARKET, 2025–2030 172
FIGURE 50 GROWTH IN NUMBER OF VETERINARIANS IN NORTH AMERICA 174
FIGURE 51 NORTH AMERICA: PET POPULATION, 2024 174
FIGURE 52 NORTH AMERICA: NUMBER OF VETERINARIANS, 2023 175
FIGURE 53 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET SNAPSHOT 175
FIGURE 54 US: TOTAL PET HEALTH EXPENDITURE (2018–2024) 180
FIGURE 55 EUROPE: PET POPULATION (MILLION), 2023 188
FIGURE 56 EUROPE: NUMBER OF VETERINARIANS, 2022 188
FIGURE 57 ASIA PACIFIC: DOG POPULATION, BY COUNTRY, 2024 218
FIGURE 58 ASIA PACIFIC: CAT POPULATION, BY COUNTRY, 2024 218
FIGURE 59 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET SNAPSHOT 219
FIGURE 60 LATIN AMERICA: PET POPULATION, 2022 250
FIGURE 61 MIDDLE EAST & AFRICA: CAT POPULATION, 2024 265
FIGURE 62 REVENUE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2020?2024) 286
FIGURE 63 SHARE ANALYSIS OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET (2024) 287
FIGURE 64 RANKING OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2024 289
FIGURE 65 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX, 2024 290
FIGURE 66 VETERINARY DERMATOLOGY MARKET: COMPANY FOOTPRINT, 2024 291
FIGURE 67 VETERINARY DERMATOLOGY MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 298
FIGURE 68 VETERINARY DERMATOLOGY MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 301
FIGURE 69 R&D EXPENDITURE OF KEY PLAYERS IN VETERINARY DERMATOLOGY MARKET, 2021?2023 302
FIGURE 70 EV/EBITDA FOR TOP COMPANIES 302
FIGURE 71 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA
OF KEY VENDORS 303
FIGURE 72 ELANCO ANIMAL HEALTH INCORPORATED: COMPANY SNAPSHOT (2024) 308
FIGURE 73 MERCK & CO., INC: COMPANY SNAPSHOT (2024) 314
FIGURE 74 VIRBAC: COMPANY SNAPSHOT (2023) 320
FIGURE 75 ZOETIS INC.: COMPANY SNAPSHOT (2024) 325
FIGURE 76 BOEHRINGER INGELHEIM INTERNATIONAL GMBH: COMPANY SNAPSHOT (2023) 331
FIGURE 77 VETOQUINOL: COMPANY SNAPSHOT (2023) 335
FIGURE 78 DECHRA PHARMACEUTICALS PLC: COMPANY SNAPSHOT (2023) 338
FIGURE 79 HESTER BIOSCIENCES LIMITED: COMPANY SNAPSHOT (2023) 342
FIGURE 80 PETIQ, INC.: COMPANY SNAPSHOT (2023) 345
FIGURE 81 OUROFINO SAUDE ANIMAL: COMPANY SNAPSHOT (2023) 347
FIGURE 82 SWEDENCARE: COMPANY SNAPSHOT (2023) 350
FIGURE 83 ORION CORPORATION: COMPANY SNAPSHOT (2023) 354
FIGURE 84 NORBROOK: COMPANY SNAPSHOT (2023) 356

List of Tables

TABLE 1 STANDARD CURRENCY CONVERSION RATES (UNIT OF USD) 35
TABLE 2 PET (DOGS AND CATS) OWNERSHIP STATISTICS IN US, 2024 66
TABLE 3 COMPANION ANIMAL POPULATION STATISTICS, BY REGION 67
TABLE 4 MAJOR OUTBREAKS OF ZOONOTIC DISEASES, 2022–2023 69
TABLE 5 AVERAGE ANNUAL PREMIUM: US AND CANADA (USD) 71
TABLE 6 VETERINARY DERMATOLOGY MARKET: IMPACT OF PORTER’S FIVE FORCES ANALYSIS 79
TABLE 7 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 8 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 9 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 10 REST OF THE WORLD: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
TABLE 11 VETERINARY DERMATOLOGY MARKET: LIST OF MAJOR PATENTS 90
TABLE 12 IMPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY BY COUNTRY (2022–2024) (USD) 91
TABLE 13 EXPORT DATA FOR PRODUCTS RELATED TO VETERINARY DERMATOLOGY BY COUNTRY (2022–2024) (USD) 91
TABLE 14 AVERAGE SELLING PRICE TRENDS OF KEY PLAYERS, BY PRODUCT TYPE 2022–2024 93
TABLE 15 AVERAGE SELLING PRICE OF VETERINARY DERMATOLOGY PRODUCT TYPES BY REGION, 2022–2024 94
TABLE 16 VETERINARY DERMATOLOGY MARKET: KEY CONFERENCES AND EVENTS (2025?2026) 96
TABLE 17 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 97
TABLE 18 KEY BUYING CRITERIA FOR VETERINARY DERMATOLOGY PRODUCTS 98
TABLE 19 UNMET NEEDS/END USER EXPECTATIONS IN VETERINARY DERMATOLOGY MARKET 98
TABLE 20 VETERINARY DERMATOLOGY MARKET: IMPACT OF GENERATIVE AI 99
TABLE 21 VETERINARY DERMATOLOGY MARKET: ROLE OF COMPANIES IN ECOSYSTEM 100
TABLE 22 VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 109
TABLE 23 VETERINARY DERMATOLOGY MARKET: TOPICAL PRODUCTS AVAILABLE 110
TABLE 24 TOPICAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY/REGION 2023–2030 (USD MILLION) 112
TABLE 25 VETERINARY DERMATOLOGY MARKET: INJECTABLE PRODUCTS AVAILABLE 113
TABLE 26 INJECTABLES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 114
TABLE 27 VETERINARY DERMATOLOGY MARKET: ORAL PRODUCTS AVAILABLE 115
TABLE 28 ORAL: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 116
TABLE 29 VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 118
TABLE 30 VETERINARY DERMATOLOGY MARKET: ANTIPARASITIC DRUGS AVAILABLE 119
TABLE 31 VOLUME DATA FOR ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (THOUSAND UNITS) 120
TABLE 32 ANTIPARASITIC DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 121
TABLE 33 VETERINARY DERMATOLOGY MARKET: ANTIFUNGAL DRUGS AVAILABLE 122
TABLE 34 ANTIFUNGAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 124
TABLE 35 VETERINARY DERMATOLOGY MARKET: ANTIBACTERIAL DRUGS AVAILABLE 125
TABLE 36 ANTIBACTERIAL DRUGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126
TABLE 37 VETERINARY DERMATOLOGY MARKET: MONOCLONAL ANTIBODIES AVAILABLE 127
TABLE 38 MONOCLONAL ANTIBODIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 39 VETERINARY DERMATOLOGY MARKET: OTHER PRODUCTS AVAILABLE 129
TABLE 40 OTHER PRODUCT TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 41 VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 132
TABLE 42 PARASITIC INFECTIONS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 43 INFECTIOUS DISEASES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 44 AUTOIMMUNE SKIN DISEASES: VETERINARY DERMATOLOGY MARKET BY COUNTRY, 2023–2030 (USD MILLION) 137
TABLE 45 SKIN CANCER: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 139
TABLE 46 OTHER CONDITION TYPES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 141
TABLE 47 VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 143
TABLE 48 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET 2023–2030 (USD MILLION) 144
TABLE 49 COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 145
TABLE 50 DOGS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 147
TABLE 51 CATS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 149
TABLE 52 HORSES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 151
TABLE 53 OTHER COMPANION ANIMALS: VETERINARY DERMATOLOGY MARKET BY COUNTRY, 2023–2030 (USD MILLION) 153
TABLE 54 LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 155
TABLE 55 CATTLE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 157
TABLE 56 SWINE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 159
TABLE 57 POULTRY: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 161
TABLE 58 OTHER LIVESTOCK ANIMALS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163
TABLE 59 VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 165
TABLE 60 VETERINARY HOSPITALS AND CLINICS: VETERINARY DERMATOLOGY MARKET BY COUNTRY, 2023–2030 (USD MILLION) 166
TABLE 61 ANIMAL SHELTERS AND RESCUES: VETERINARY DERMATOLOGY MARKET BY COUNTRY, 2023–2030 (USD MILLION) 168
TABLE 62 OTHER END USERS: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 170
TABLE 63 VETERINARY DERMATOLOGY MARKET, BY REGION, 2023–2030 (USD MILLION) 173
TABLE 64 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 176
TABLE 65 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 176
TABLE 66 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 177
TABLE 67 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 177
TABLE 68 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 178
TABLE 69 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 178
TABLE 70 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 179
TABLE 71 NORTH AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 179
TABLE 72 US: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 180
TABLE 73 US: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 181
TABLE 74 US: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 181
TABLE 75 US: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 182
TABLE 76 US: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 182
TABLE 77 US: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 182
TABLE 78 US: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 183
TABLE 79 CANADA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 184
TABLE 80 CANADA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 184
TABLE 81 CANADA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 185
TABLE 82 CANADA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 185
TABLE 83 CANADA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 186
TABLE 84 CANADA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 186
TABLE 85 CANADA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 187
TABLE 86 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 189
TABLE 87 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 189
TABLE 88 EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 190
TABLE 89 EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 190
TABLE 90 EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 191
TABLE 91 EUROPE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 191
TABLE 92 EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 192
TABLE 93 EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 192
TABLE 94 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 193
TABLE 95 GERMANY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 193
TABLE 96 GERMANY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 194
TABLE 97 GERMANY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 194
TABLE 98 GERMANY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 195
TABLE 99 GERMANY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 195
TABLE 100 GERMANY: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 196
TABLE 101 UK: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION 2023–2030 (USD MILLION) 197
TABLE 102 UK: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 197
TABLE 103 UK: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 198
TABLE 104 UK: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 198
TABLE 105 UK: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 199
TABLE 106 UK: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 199
TABLE 107 UK: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 200
TABLE 108 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 200
TABLE 109 FRANCE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 201
TABLE 110 FRANCE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 201
TABLE 111 FRANCE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 202
TABLE 112 FRANCE: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 202
TABLE 113 FRANCE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 203
TABLE 114 FRANCE: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 203
TABLE 115 ITALY: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 204
TABLE 116 ITALY: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 204
TABLE 117 ITALY: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 205
TABLE 118 ITALY: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 205
TABLE 119 ITALY: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 205
TABLE 120 ITALY: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 206
TABLE 121 ITALY: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 206
TABLE 122 SWITZERLAND: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 207
TABLE 123 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 207
TABLE 124 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 208
TABLE 125 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 208
TABLE 126 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 209
TABLE 127 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 209
TABLE 128 SWITZERLAND: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 210
TABLE 129 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 210
TABLE 130 SPAIN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 211
TABLE 131 SPAIN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 211
TABLE 132 SPAIN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 212
TABLE 133 SPAIN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 212
TABLE 134 SPAIN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 213
TABLE 135 SPAIN: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 213
TABLE 136 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 214
TABLE 137 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 214
TABLE 138 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 215
TABLE 139 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 215
TABLE 140 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 216
TABLE 141 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 216
TABLE 142 REST OF EUROPE: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 217
TABLE 143 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 220
TABLE 144 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 220
TABLE 145 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 221
TABLE 146 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 221
TABLE 147 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 222
TABLE 148 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 222
TABLE 149 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 223
TABLE 150 ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 223
TABLE 151 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 224
TABLE 152 JAPAN: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 224
TABLE 153 JAPAN: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 225
TABLE 154 JAPAN: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 225
TABLE 155 JAPAN: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 226
TABLE 156 JAPAN: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 226
TABLE 157 JAPAN: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 227
TABLE 158 CHINA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 228
TABLE 159 CHINA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 228
TABLE 160 CHINA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 229
TABLE 161 CHINA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 229
TABLE 162 CHINA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 230
TABLE 163 CHINA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 230
TABLE 164 CHINA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 231
TABLE 165 INDIA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 232
TABLE 166 INDIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 232
TABLE 167 INDIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 233
TABLE 168 INDIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 233
TABLE 169 INDIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 234
TABLE 170 INDIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 234
TABLE 171 INDIA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 235
TABLE 172 AUSTRALIA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 235
TABLE 173 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 236
TABLE 174 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 236
TABLE 175 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 237
TABLE 176 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 237
TABLE 177 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 238
TABLE 178 AUSTRALIA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 238
TABLE 179 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 239
TABLE 180 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 239
TABLE 181 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 240
TABLE 182 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 240
TABLE 183 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 241
TABLE 184 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 241
TABLE 185 NEW ZEALAND: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 242
TABLE 186 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 242
TABLE 187 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 243
TABLE 188 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 243
TABLE 189 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 244
TABLE 190 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 244
TABLE 191 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 245
TABLE 192 SOUTH KOREA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 245
TABLE 193 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 246
TABLE 194 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 246
TABLE 195 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 247
TABLE 196 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 247
TABLE 197 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 248
TABLE 198 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 248
TABLE 199 REST OF ASIA PACIFIC: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 249
TABLE 200 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 250
TABLE 201 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 251
TABLE 202 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 251
TABLE 203 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 252
TABLE 204 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 252
TABLE 205 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 253
TABLE 206 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 253
TABLE 207 LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 254
TABLE 208 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 255
TABLE 209 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 255
TABLE 210 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 256
?
TABLE 211 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 256
TABLE 212 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 257
TABLE 213 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 257
TABLE 214 BRAZIL: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 258
TABLE 215 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 258
TABLE 216 MEXICO: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 259
TABLE 217 MEXICO: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 259
TABLE 218 MEXICO: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 260
TABLE 219 MEXICO: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 260
TABLE 220 MEXICO: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 260
TABLE 221 MEXICO: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 261
TABLE 222 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 261
TABLE 223 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY PRODUCT TYPE, 2023–2030 (USD MILLION) 262
TABLE 224 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY CONDITION TYPE, 2023–2030 (USD MILLION) 262
TABLE 225 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 263
TABLE 226 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 263
TABLE 227 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 263
TABLE 228 REST OF LATIN AMERICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 264
TABLE 229 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 265
TABLE 230 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 265
TABLE 231 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET BY CONDITION TYPE, 2023–2030 (USD MILLION) 266
TABLE 232 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE, 2023–2030 (USD MILLION) 266
TABLE 233 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 267
?
TABLE 234 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 267
TABLE 235 MIDDLE EAST & AFRICA: VETERINARY DERMATOLOGY MARKET, BY END USER, 2023–2030 (USD MILLION) 267
TABLE 236 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COUNTRY 2023–2030 (USD MILLION) 268
TABLE 237 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 268
TABLE 238 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 269
TABLE 239 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE, 2023–2030 (USD MILLION) 269
TABLE 240 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 270
TABLE 241 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS, 2023–2030 (USD MILLION) 270
TABLE 242 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS, 2023–2030 (USD MILLION) 270
TABLE 243 GCC COUNTRIES: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 271
TABLE 244 KSA: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 271
TABLE 245 KSA: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 272
TABLE 246 KSA: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 272
TABLE 247 KSA: VETERINARY DERMATOLOGY MARKET, BY ANIMAL TYPE 2023–2030 (USD MILLION) 273
TABLE 248 KSA: VETERINARY DERMATOLOGY MARKET, BY COMPANION ANIMALS 2023–2030 (USD MILLION) 273
TABLE 249 KSA: VETERINARY DERMATOLOGY MARKET, BY LIVESTOCK ANIMALS 2023–2030 (USD MILLION) 273
TABLE 250 KSA: VETERINARY DERMATOLOGY MARKET, BY END USER 2023–2030 (USD MILLION) 274
TABLE 251 UAE: VETERINARY DERMATOLOGY MARKET, BY ROUTE OF ADMINISTRATION, 2023–2030 (USD MILLION) 274
TABLE 252 UAE: VETERINARY DERMATOLOGY MARKET, BY PRODUCT TYPE 2023–2030 (USD MILLION) 275
TABLE 253 UAE: VETERINARY DERMATOLOGY MARKET, BY CONDITION TYPE 2023–2030 (USD MILLION) 275
TABLE 254 UAE: VETERINARY D